ArticleNeurology and therapy2024

Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study.

Patricia Pozo-Rosich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.